Reduced protein expression of the cardiac ryanodine receptor (RyR2) is thought to affect the susceptibility to stress-induced ventricular tachyarrhythmia (VT) and cardiac alternans, but direct evidence for the role of RyR2 protein expression in VT and cardiac alternans is lacking. Here we used a mouse model (crr m1 ) that expresses a reduced level of the RyR2 protein to determine the impact of reduced RyR2 protein expression on the susceptibility to VT, cardiac alternans, cardiac hypertrophy, and sudden death. Electrocardiography (ECG) analysis revealed that after the injection of relatively high doses of caffeine and epinephrine (agents commonly used for stress test), wildtype (WT) mice displayed long-lasting VTs, whereas, the crr m1 mutant mice exhibited no VTs at all, indicating that the crr m1 mutant mice are resistant to stress-induced VTs. Intact heart Ca 2+ imaging and action potential (AP) recordings showed that the crr m1 mutant mice are more susceptible to fast-pacing induced Ca 2+ alternans and AP duration alternans compared with WT mice. The crr m1 mutant mice also showed increased heart weight-to-body weight ratio and incidence of sudden death at young ages. Furthermore, the crr m1 mutant hearts displayed altered Ca 2+ transients with increased time-to-peak and decay time (T50), increased ventricular wall thickness and ventricular cell area compared with WT hearts. These results indicate that reduced RyR2 protein expression suppresses stress-induced VTs, but enhances the susceptibility to cardiac alternans, hypertrophy, and sudden death.
INTRODUCTION
Ryanodine receptor type 2 (RyR2) is the major Ca 2+ release channel expressed in the sarcoplasmic reticulum (SR) of cardiac muscle cells. It plays an essential role in excitationcontraction coupling by governing SR Ca 2+ release, which causes muscle contraction [1] . Given its important role in cardiac function, dysfunction of RyR2 can lead to various cardiac disorders.
EXPERIMENTAL PROCEDURES Animal studies
All animal studies were approved by the Institutional Animal Care and Use Committees at the University of Calgary and were performed in accordance with US National Institutes of Health guidelines. The RyR2-targeted mutant mouse (crr m1 ) was generated as described previously [19] . Adult homozygous crr m1 mutant mice and wildtype (WT) littermates (8-10 weeks) in the 129-E mouse background (Charles River) were used for all experiments. Note that in the study by Takeshima et al [19] , two RyR2 mutant mouse lines were generated: one is a RyR2-targeted mutant mouse called crr m1 and the other is a Cre-recombined RyR2 mutant mouse called crr m2 . In the crr m1 mutant mice, a loxP sequence was inserted into the 5'-untranslation region in exon 1, and a cassette containing a loxP sequence, the green fluorescence protein (GFP) cDNA, and the neomycin resistance gene (Neo) was inserted into the first intron of the mouse ryr2 gene. In the crr m2 mutant mice, the DNA sequence between the two loxP sites has been removed using the Cremediated recombination, resulting in the deletion of exon 1 and thus the RyR2 knockout (KO). Takeshima et al. used the crr m2 mutant mice to study the impact of RyR2 KO on the heart. In the present study, we used the crr m1 mutant mice without subjecting them to Cre-mediated recombination.
Western blot analysis
The crr m1 mutant and WT mouse hearts were frozen by a liquid N2-precooled Wollenberger clamp. The frozen heart tissues were ground to powder in the presence of liquid N2 and homogenated in the homogenizing buffer (30 mM KH2PO4, pH 7.0, 40 mM NaF, 5 mM EDTA, 0.3 M Sucrose, 4 μmol/L Leupeptin, 1 mM Benzamidine, 100 μmol/L PMSF, 0.5 mM DTT) using a precooled Brinkmann Polytron PT 15 homogenizer. The cell homogenate (100 μl) was solubilized in a final 500 μl buffer containing 3% SDS and 50 mM Tris-HCl (pH 7.5) at room temperature for one hour and incubated at 55°C for 10 minutes before centrifugation to remove unsolubilized materials. The solubilized proteins from WT or the crr m1 mutant hearts were separated by 6%, 8% or 15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to nitrocellulose membranes at 100 V for 1.5 hours at 4°C in the presence of 0.01% SDS [29, 30] . The nitrocellulose membranes were then blocked for one hour with phosphate buffered saline (PBS: 137 mM NaCl, 8 mM Na2HPO4, 1.5 mM KH2PO4 and 2.7 mM KCl, pH 7.4) containing 0.5% Tween-20 and 5% skim milk powder. The membranes were incubated separately with the anti-RyR (34c, mouse), anti-Cav1.2 (rabbit), anti-SERCA (rabbit), anti-NCX (mouse), anti-CASQ2 (rabbit), or anti-β-actin (rabbit) antibodies (Thermo Fisher Scientific) to detect the expression level of major Ca 2+ handling proteins. The membranes were washed three times with PBS containing 0.5% Tween-20 for 15 minutes before incubating with the corresponding secondary anti-IgG antibodies conjugated with horseradish peroxidase (1:20,000) (Thermo Fisher Scientific) for 30 minutes. The detection of the bound antibodies was enhanced by chemiluminescence kit from Pierce and visualized by ImageQuant LAS 4000 from GE Healthcare Life Sciences.
Hematoxylin and eosin (H&E) staining
Hearts from the crr m1 mutant mice and their WT littermates were isolated and washed with Krebs-Ringers-HEPES (KRH) buffer (125 mM NaCl, 12.5 mM KCl, 25 mM HEPES, pH 7.4, 6 mM glucose, and 1.2 mM MgCl2) and fixed with 4% paraformaldehyde solution via retrograde Langendorf perfusion system. The fixed hearts were cut across the long axis to show the four chambers and then put into tissue cassettes. The dehydrating, clearing and paraffining were performed using Leica ASP300S tissue processor. The paraffin embedded blocks were cut at 5μm thick and mounted onto slides, air-dried for 30 minutes at room temperature and were baked at 37°C overnight. The paraffin sections were deparaffinized by xylene and rehydrated through ethanol and tap water before labeling with hematoxylin. Three minutes after stained with hematoxylin, the slides were rinsed in 1% acid alcohol (70%) several times to remove free hematoxylin and then were immersed in PBS for dark-blue color reaction product. Thereafter, washed with distilled water and then stained with Eosin for 3 minutes. The H&E stained slides were dehydrated in alcohol, cleared in xylene and mounted with coverslips. Photomicrographs were captured with a bright filed microscope (Olympus BX53).
Electrocardiographic (ECG) recordings and induction of cardiac arrhythmias in anesthetized mice
The crr m1 mutant and WT mice were lightly anesthetized with isoflurane vapor (0.5-1%) and 95% O2 and placed on a heating pad (27°C). Two subcutaneous needle electrodes were inserted into the right upper limb and left lower abdomen for ECG recordings (BIOPAC MP System, Goleta, CA). The ECGs were continuously monitored under anesthesia until heart rate became stable. Baseline ECGs were recorded for 5-10 minutes before stimulation. For induction of ventricular arrhythmias, mutant mice and their WT littermates were subjected to intraperitoneal injection of epinephrine (1.6 mg/kg) and caffeine (120 mg/kg) (low dose), or were injected with 3.0 mg/kg epinephrine and 150 mg/kg caffeine (high dose). ECGs were continuously recorded for 30 minutes after the infusion of epinephrine and caffeine [31] .
Monophasic action potential (MAP) recordings in Langendorff-perfused hearts
The crr m1 mutant and WT mice were sacrificed by cervical dislocation. Their hearts were cannulated to a Langendorff apparatus for maintaining coronary perfusion with oxygenated Tyrode's buffer (118 mM NaCl, 5.4 mM KCl, 25 mM NaHCO3, 1 mM MgCl2, 0.42 mM NaH2PO4, 11.1 mM glucose, 10 mM taurine, 5 mM creatine, pH 7.4) containing 1.8 mM Ca 2+ at 35°C. A monophasic action potential electrode was placed against the epicardial surface of the lower middle part of the left ventricle for epicardial MAP recording. Baseline MAP was recorded for 5-10 minutes before pacing at the right atrium from 5 to10 Hz at 4-10 V for >20 seconds to induce APD alternans. The total length of the recording was 30 minutes. MAP signals were amplified by Gould amplifiers (models 13-G 4615-58, 13-4615-50 and 13-4615-71) and acquired at 2000 Hz/channel using a Data Translation (DT 2821) analog and digital input-output board. Analysis of MAP signals was performed using Acknowledgment (BIOPAC MP System, Goleta, CA).
Laser scanning confocal Ca 2+ imaging of intact hearts
The crr m1 mutant mice and WT littermates were sacrificed by cervical dislocation. Their hearts were cannulated to a Langendorff apparatus for maintaining coronary perfusion with oxygenated Ca 2+ free Tyrode's buffer for 3-5 minutes and loaded with 4.4 μM Rhod-2 AM (Biotium, Inc. Hayward, CA) for about 45 minutes at 25°C [32, 33] . Extracellular Ca 2+ was stepwise introduced to the heart from 0.25, 0.5, 1.0, to 1.8 mM in the presence of 5 μM blebbistatin (Toronto Research Chemicals, Toronto, ON) at 35°C throughout the experiment. The Langendorffperfused hearts were placed on a recording chamber mounted onto the Nikon A1R microscope for in situ confocal imaging (line-scan) of Ca 2+ signals from epicardial ventricular myocytes. The pixel size of the resulting line-scan images ranged between 1.8 and 2 ms in the temporal dimension and between 0.1 to 0.4 microns in the spatial dimension. Ca 2+ alternans was induced by rapid electrical stimulation of the hearts at increasing frequencies (5-12 Hz, 6 V). Data analysis was performed using NikonA1R analysis system and Image J software.
Image and signal processing
The following signal and image processing methods were implemented using MATLAB (The Mathworks Inc., Boston, MA) as described previously [34, 35] . Briefly, Line-scan fluorescence images were filtered using a median filter applied iteratively a number of times according to an estimation of the image noise variance. Noise variance was robustly estimated by means of a median absolute deviation of the image pixels. Identification of individual cells in the line-scan was performed by manually labeling the cell regions. Average fluorescence signals of individual cells in each line-scan were automatically obtained by spatial averaging of the pixels belonging to each marked cell. Average fluorescence signals of single cells were further filtered by applying a continuous wavelet transform of the signal with Gaussian wavelets of order 2. Zerocrossing of the derivative of the resulting wavelet transform was used to accurately locate peaks and valleys in the fluorescence signals. Peaks were then classified as either stimulated or spontaneous using cross-correlation with the stimulation pulse train. Peak amplitudes were defined as the difference between the peak and the corresponding previous valley. For each cell, alternans ratio was measured as the ratio of the absolute value of the difference in amplitude between two consecutive peaks over the amplitude of the largest peak. The presence of alternans periods was established by requiring at least six consecutive stimulated peaks presenting an alternans ratio above 0.05. For each cell, alternans duration was defined as the cumulative elapsed time of alternans periods over the total duration of the line-scan. The average alternans duration was determined by averaging alternans durations of all cells in one scan area; and the average alternans ratio was determined by averaging alternans ratios of cells that displayed alternans in the same scan area.
Echocardiography
Echocardiographic analysis of the WT and crr m1 mutant mice was carried out using the Vevo 770 echocardiography system equipped with a 30 MHz transducer probe (Visual Sonics, Toronto, Canada) as described previously [36] . Mice (8-9 weeks old) were gently constrained on a heating pad (37 o C) and anesthetized with 1.5-2% isoflurane. Parameters, including the end systolic and diastolic diameters of the left chamber, interventricular septum and posterior wall thickness, left ventricular fractional shortening, and ejection fraction were analyzed for each mouse in a blinded manner involving the B-Mode and M-Mode measurements. All data were averaged from 10 cardiac cycles per mouse.
Statistical Analysis
All values shown are mean ± SEM unless indicated otherwise. To test for differences between groups, we used unpaired Student's t-test (2-tailed) or one-way ANOVA with post hoc test. A P value <0.05 was considered to be statistically significant.
RESULTS

Modification of the ryr2 gene for gene-targeted knock-out markedly reduces the protein expression of RyR2
During the process of generating the RyR2 knock-out mice, Takeshima et al [19] previously produced a targeted mutant mouse (crr m1 ), in which a loxP sequence was inserted into the 5'-untranslation region, and a cassette containing a loxP sequence, the green fluorescence protein (GFP) cDNA, and the neomycin resistance gene (Neo) inserted into the first intron of the mouse ryr2 gene (Fig. 1A) . Although these insertions in the intron sequences generally have minimal impact on gene organization and expression, surprisingly, we found that homozygous crr m1 mutant mice displayed markedly reduced expression of the RyR2 protein. Immunoblotting analyses of whole heart lysates revealed that the expression level of the RyR2 protein in the crr m1 mutant hearts was substantially reduced compared with that in the WT hearts (23.3 ± 4.5% vs WT, p<0.01) (Fig. 1B, C) . On the other hand, there were no significant differences in the expression levels of other major Ca 2+ handling proteins between the crr m1 mutant and WT hearts, including the L-type Ca 2+ channel, Na + /Ca 2+ exchanger, the sarco/endoplasmic reticulum Ca 2+ ATPase (SERCA), and calsequestrin (CASQ2) (Fig. 1B, C) . Therefore, the crr m1 mutant mice express a markedly reduced level of RyR2 protein, and represent a useful model for studying the impact of reduced RyR2 protein expression.
Reducing RyR2 protein expression protects against stress-induced ventricular tachyarrhythmia
It has been suggested that the level of RyR2 protein may play an important role in determining the susceptibility to catecholaminergic polymorphic ventricular tachycardia (CPVT) [22, 24, 37] . However, direct evidence for the role of RyR2 protein expression in CPVT is lacking. To this end, we took advantage of the crr m1 mouse model to assess the impact of reduced RyR2 WT protein expression on stress-induced ventricular tachyarrhythmia (VT). We monitored the occurrence of VTs in WT and crr m1 mutant mice using electrocardiography (ECG) recordings before and after the injection of a mixture of caffeine (120 mg/kg) and epinephrine (1.6 mg/kg). This combination of pharmacological reagents has been widely used to trigger VTs in mouse models of CPVT [31, 33, [38] [39] [40] . Consistent with those reported previously, WT mice showed short-durations of VTs (5.7 ± 4.1%) over the 30-min period of ECG recordings after the injection of these triggers ( Fig. 2A, E, F) . Interestingly, not a single episode of VTs was detected in the crr m1 mutant mice under the same conditions (Fig. 2C , E, F). These observations raise the possibility that the crr m1 mutant mice may be protected against stress-induced VTs. To test this hypothesis, we repeated the stress tests in WT and crr m1 mutant mice using higher doses of caffeine (150 mg/kg) and epinephrine (3.0 mg/kg). As expected, high doses of caffeine and epinephrine induced severe polymorphic and bidirectional VTs in WT mice with an average VT duration of 46.3 ± 16.0% over the 30-min period of ECG recordings (Fig. 2B, E, F) . Remarkably, the crr m1 mutant mice showed no VTs at all after the injection of high doses of caffeine and epinephrine (Fig. 2D, E, F) . Thus, the crr m1 mutant mice are resistant to stress-induced VTs. Taken together, these observations indicate that reducing RyR2 WT protein expression can protect against stress-induced VTs in mice.
Reducing RyR2 protein promotes Ca 2+ alternans in intact hearts
We have previously shown that inhibiting the luminal Ca 2+ activation of RyR2 suppresses stress-induced VTs, but enhances Ca 2+ alternans [35] . It is possible that reducing the expression of the RyR2 protein, which suppresses stress-induced VTs, may also affect Ca 2+ alternans. To test this possibility, we assessed the intracellular Ca 2+ dynamics in intact working WT and the crr m1 mutant hearts stimulated at increasing frequencies (5-10 Hz) using in situ confocal laser scanning Ca 2+ imaging. Figure 3 shows representative images and traces of Ca 2+ transients obtained from WT and the crr m1 mutant hearts stimulated at 7 Hz. At this stimulation frequency, little or no Ca 2+ alternans was detected in the WT hearts (Fig. 3A) , whereas, the crr m1 mutant hearts showed severe Ca 2+ alternans (Fig. 3B) . The average duration of Ca 2+ alternans was 80.2 ± 4.6% in the crr m1 mutant hearts versus 10.6 ± 3.0% in the WT hearts. The average alternans ratio was 57.3 ± 4.4% in the crr m1 mutant hearts versus 5.8 ± 1.7% in the WT hearts (Fig. 3C,D) . Furthermore, the threshold stimulation frequency at which Ca 2+ alternans occurred was lower in the crr m1 mutant hearts than in the WT hearts (Fig. 4) . Ca 2+ alternans was readily detected in the crr m1 mutant hearts at a stimulation frequency of 5 Hz, whereas, higher stimulation frequencies (8-10 Hz) were required to induce Ca 2+ alternans in WT hearts (Fig. 4) . Moreover, the crr m1 mutant hearts displayed significantly longer alternans durations and higher alternans ratios at 5-10 Hz compared with the WT hearts at the same stimulation frequencies (Fig. 4A,B) . It should be noted that reducing RyR2 protein expression also affected the properties of Ca 2+ transients. The crr m1 mutant hearts showed significantly increased time-to-peak and decay time (T50), but similar amplitude of Ca 2+ transients compared to WT hearts (Fig. 5) . Collectively, these observations indicate that reduced RyR2 protein expression enhances the susceptibility to Ca 2+ alternans.
Reducing RyR2 protein enhances action potential duration alternans
We next determined whether reduced RyR2 protein expression affects the propensity for action potential duration (APD) alternans. Monophasic action potential (MAP) was recorded in Langendorff-perfused WT and the crr m1 mutant hearts. The hearts were stimulated with increasing frequencies from 5 to 10 Hz to induce action potential duration alternans. As shown in Fig. 6 , WT hearts showed little or no APD alternans at the stimulation frequency of 8 Hz (Fig. 6A) , whereas, the crr m1 mutant hearts exhibited significant APD alternans at the same stimulation frequency (8 Hz) (Fig. 6B) . As the stimulation frequency increased from 5 to 10 Hz, the ratios of APD alternans increased in both the WT and the crr m1 mutant hearts (Fig. 6C) . However, the APD alternans ratio in the crr m1 mutant hearts was significantly higher than that in the WT hearts at each stimulation frequency (between 6-10 Hz). For instance, at 8 Hz, the average APD alternans ratio was 2.6 ± 0.9% in WT hearts and 19.5 ± 5.6% in the crr m1 mutant hearts (Fig. 6C) . These results indicate that reduced RyR2 protein expression enhances the susceptibility to APD alternans.
The crr m1 mutant mice display cardiac hypertrophy and sudden death
Tissue-specific, conditional KO of RyR2 in the heart resulted in cardiac hypertrophy and sudden death [20] . To determine whether constitutively reducing RyR2 protein expression can lead to cardiac hypertrophy and sudden death, we assessed and compared the weights of the WT and crr m1 mutant hearts of the WT and crr m1 mutant mice. Hematoxylin and eosin (H&E) staining of paraformaldehyde fixed heart sections revealed increased thickness of the ventricular walls (Fig.  7A ) and ventricular cell area (Fig. 7B,C) in the crr m1 mutant hearts compared with those in WT hearts. Consistent with these observations, echocardiographic analyses also revealed increased ventricular wall thickness in the crr m1 mutant hearts compared with the WT hearts (Table 1) . Furthermore, the crr m1 mutant mice showed a significant increase in the heart weight-to-body weight ratio compared with the WT mice (56.0 ± 2.8% in crr m1 vs 40.7 ± 2.6% in WT) (Fig. 7D ). Similar to that observed with the conditional RyR2 KO mice [20] , we also found that the crr m1 mutant mice exhibited sudden death at young ages, starting at ~40 days (Fig. 8) . On the other hand, no sudden death was observed with the WT mice (Fig. 8) . Taken together, these results indicate that reducing RyR2 protein expression can lead to cardiac hypertrophy and increase the incidence of sudden death.
DISCUSSION
Although reduced RyR2 protein expression is likely to occur under various cardiac conditions, the impact of reduced RyR2 protein level on cardiac function is not well understood. In the present study, we exploited a mutant mouse model with reduced RyR2 protein expression. We found that reducing the protein expression of RyR2 suppresses stress-induced VTs, but enhances Ca 2+ alternans and APD alternans. In addition, reduced RyR2 protein expression led to cardiac hypertrophy and increased the susceptibility to sudden death. These findings provide novel insights into the role of RyR2 protein expression in VTs and cardiac alternans.
A remarkable finding from the present study is that mice with reduced RyR2 WT protein expression are resistant to stress-induced VTs, suggesting that the level of RyR2 WT protein expression can affect the propensity for stress-induced VTs. It has been shown that the severity of CPVT phenotypes in individuals with the same RyR2 mutations (e.g. deletion of exon-3 or G357S) can differ substantially [23, [25] [26] [27] [28] . Although the exact mechanism underlying the phenotypic variability in the same families or in individuals with the same mutations is unknown, our finding suggests that reduced RyR2 protein expression may be one of the many factors that determine the penetrance of CPVT. It is possible that some CPVT-linked RyR2 mutations alter not only the gating properties of RyR2, but also its protein expression, which would in turn affect the propensity for CPVT. In support of this view, we have previously shown that deletion of exon-3 and the point mutation G357S markedly reduce the protein expression of RyR2, which may contribute to the incomplete penetrance of CPVT in individuals with these mutations [22] [23] [24] . Interestingly, Bongianino et al [37] recently employed RNA interference to specifically reduce the protein expression of the RyR2 mutant allele in a CPVT mouse model expressing the RyR2 mutation R4496C. They found that allelic silencing of the RyR2 R4496C mutant expression is able to prevent CPVT in these mice. These observations suggest that reducing the expression of the RyR2 mutant protein represents a promising strategy for the treatment of CPVT. Our data would further suggest that reducing the expression level of the total RyR2 protein (both WT and mutant) may also be protective against CPVT. In this regard, it would be of great interest to determine whether individuals with nonsense or frame-shift RyR2 mutations that result in haploinsufficiency display reduced or enhanced susceptibility to CPVT.
It is important to note that suppressed RyR2 activity has been shown to enhance cardiac alternans [35] . Furthermore, reduced RyR2 protein expression has been implicated in the genesis of cardiac alternans [21] . Consistent with these observations, we found that reducing the protein expression of RyR2 indeed increases the propensity for Ca 2+ and AP-duration alternans. Hence, although reducing the level of RyR2 protein expression can suppress stress-induced VTs, it can also increase the propensity for Ca 2+ and APD alternans, a well-known cause of re-entrant arrhythmias that can lead to ventricular fibrillation and sudden death. Therefore, reducing the protein expression of RyR2 has the beneficial effect of suppressing stress-induced VTs, but the adverse effect of promoting cardiac alternans. Since cardiac alternans usually occurs at fast heart rates, one may be able to minimize the adverse effect of reduced RyR2 protein expression on cardiac alternans by controlling the heart rate. It is also important to note that reduced RyR2 protein expression also increases the risk of developing cardiac hypertrophy and sudden death [20] . Hence, a future challenge would be to fine tune the protein expression of RyR2, in addition to normalizing the activity of RyR2, in order to maximize its suppressing effect on stress-induced VTs, while minimize its adverse effect on cardiac alternans, hypertrophy, and sudden death.
The exact mechanism by which reducing RyR2 expression protects against stress-induced ventricular tachyarrhythmias (VTs), but promotes Ca 2+ and APD alternans is unknown. It has been shown that enhanced RyR2 function can increase the propensity for spontaneous SR Ca 2+ release, which in turn can lead to delayed afterdepolarization, triggered activity, and VTs [2, 3] . On the other hand, depressed RyR2 function can prolong the refractoriness of SR Ca 2+ release, which in turn can increase the propensity for Ca 2+ alternans [41] [42] [43] [44] . In summary, the present study demonstrates that reducing the protein expression of RyR2 suppresses stress-induced VTs. This effect of reduced RyR2 protein expression on VTs may contribute to the incomplete penetrance of CPVT. Reduced RyR2 protein expression also increases the propensity for cardiac alternans, hypertrophy, and sudden death. Therefore, although moderate reduction in RyR2 protein expression may protect against CPVT, severe RyR2 protein reduction may lead to adverse effects.
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CPVT, Catecholaminergic Polymorphic Ventricular Tachycardia RyR2, Cardiac Ryanodine Receptor SR, Sarcoplasmic Reticulum VT, Ventricular Tachyarrhythmia ECG, Electrocardiography MAP, Monophasic Action Potential APD, Action Potential Duration SERCA2a, Sarco/endoplasmic Reticulum Ca 2+ ATPase CASQ2, Cardiac Calsequestrin (A) Genetic manipulations in the mouse ryr2 gene are illustrated [19] . The loxP sequence was introduced into the BspEI site in exon 1 (Ex 1) and the loxP-GFP-Neo cassette was inserted into the ScaI site in intron 1 after exon 1. (B) Western blot analysis of RyR2, Cav1.2, NCX, SERCA2a, CASQ2, and β-actin expression in the crr m1 mutant and WT hearts. The same amount of heart lysate proteins was loaded in each lane, and the bands were detected using the corresponding antibodies (n = 3-4). (C) The expression level of each protein in the crr m1 mutant hearts was normalized to that of the WT hearts. Data shown are mean ± SEM (n=3-4) (** P < 0.01). Intact WT (A) and the crr m1 mutant (B) hearts were loaded with Rhod-2 AM and perfused with blebbistatin in a Langendorff setting. Ca 2+ transients were elicited by pacing at 7 Hz and recorded using laser confocal imaging in the line-scanning mode. Cell boundaries were indicated by short bars on the left. The F/Fo traces depict the average fluorescence signal of the scan area. Alternans duration for each cell in the scan area and alternans ratio for each cell that displayed alternans in the same scan area were determined and averaged per cell to yield the average alternans duration (C) and average alternans ratio (D). Alternans duration is defined as the percentage of time in alternans over the 10s scanning period, and alternans ratio is defined as the Intact WT and crr m1 mutant hearts were loaded with Rhod-2 AM and perfused with blebbistatin in a Langendorff setting. Ca 2+ transients were elicited by pacing at different frequencies from 5 to 10 Hz, and recorded using laser confocal imaging in the line-scanning mode. (A) Average alternans duration (%) in cells in WT or the crr m1 mutant hearts over the 10s scanning period. (B) The average alternans ratio for cells that displayed alternans. Data shown are mean ± SEM (n = 14 scan areas from 6 RyR2 WT hearts, n = 20 scan areas from 7 crr m1 mutant hearts) (*p<0.05, **p<0.01). Intact WT (A) and the crr m1 mutant (B) hearts were loaded with Rhod-2 AM and perfused with blebbistatin in a Langendorff setting. Ca 2+ transients were elicited by pacing at 5 Hz and recorded using laser confocal imaging in the line-scanning mode. Cell boundaries were indicated by short bars on the left. The F/Fo traces depict the average fluorescence signal of the scan area. The average transient amplitude (C), time-to-peak (D), and decay time (T50) of Ca 2+ transients in the WT and crr m1 mutant hearts are indicated. Data shown are mean ± SEM (n = 4 scan areas from 2 RyR2 WT hearts, n = 13 scan areas from 7 crr m1 mutant hearts) (**p<0.01). The APD alternans ratios of the WT and the crr m1 mutant hearts paced at different frequencies (5 -10 Hz). Data shown are mean ± SEM (n = 6 for WT hearts, n = 4 for the crr m1 mutant hearts) (*p<0.05, **p<0.01). The heart-and bodyweight ratios of the WT and crr m1 mutant hearts. Data shown are mean ± SEM (n = 4 for WT, n = 6 for crr m1 mutant mice) (** P < 0.01). The survival rate of the crr m1 mutant mice (n=32) and the WT mice (n=22) is shown. Note that no WT mice died during the period (60 days) of observation, whereas, the crr m1 mutant mice started to die at the age of 40 days.
